Processa Pharmaceuticals Inc Sustainability Reports
Processa Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company focused on developing next-generation chemotherapy drugs. The company aims to improve the safety-efficacy profile and survival rate for cancer patients who have high unmet medical needs.
Sector: Manufacturing
Country: United States
Exchange: Nasdaq
LEI: 529900A51HZIE4XJB960
FIGI: BBG003MN60F5
3 reports from 2018 to 2023